Yuli Cai
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 0.5%
- Long-Term Effects of COVID-19
Papers in
-
- Liver Disease Diagnosis and Treatment 6
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 3
- Diabetes Treatment and Management 3
- Co-authors
- Shaobo Shi (3 shared papers)Fan Yang (3 shared papers)Mu Qin (2 shared papers)Xu Liu (2 shared papers)Congxin Huang (2 shared papers)Bo Yang (2 shared papers)Bo Shen (2 shared papers)Tao Liu (2 shared papers)
- Journals
- Blood (2 papers)Molecular Biology Reports (2 papers)Frontiers in Cardiovascular Medicine (2 papers)The FASEB Journal (2 papers)Journal of Endocrinology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yuli Cai
38 papers receiving 3.7k citations
Yuli Cai's Hit Papers
Peers
Comparison fields: 5 of 113
- Infectious Diseases 2.1k
- Neurology 1.2k
- Cardiology and Cardiovascular Medicine 725
- Critical Care and Intensive Care Medicine 103
- Oncology 419
Countries citing papers authored by Yuli Cai
This map shows the geographic impact of Yuli Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuli Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuli Cai more than expected).
Fields of papers citing papers by Yuli Cai
This network shows the impact of papers produced by Yuli Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuli Cai. The network helps show where Yuli Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuli Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China Hit paper breakdown → | 2020 | 2980 |
| 2 | Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019 Hit paper breakdown → | 2020 | 331 |
| 3 | 2016 | 98 | |
| 4 | 2022 | 58 | |
| 5 | 2020 | 36 | |
| 6 | 2018 | 28 | |
| 7 | 2012 | 28 | |
| 8 | 2023 | 24 | |
| 9 | 2014 | 22 | |
| 10 | 2019 | 18 | |
| 11 | 2014 | 18 | |
| 12 | 2020 | 12 | |
| 13 | 2017 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2022 | 8 | |
| 18 | 2021 | 8 | |
| 19 | 1992 | 8 | |
| 20 | 2014 | 7 |
About Yuli Cai
Yuli Cai is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 41 papers that have together received 3.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Diabetes Treatment and Management (3 papers), Advanced Glycation End Products research (3 papers), Cardiovascular Disease and Adiposity (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). The work is most often cited by research in Infectious Diseases (2.1k citations), Neurology (1.2k citations), Cardiology and Cardiovascular Medicine (725 citations), Critical Care and Intensive Care Medicine (103 citations) and Oncology (419 citations). Yuli Cai has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shaobo Shi, Fan Yang, Mu Qin, Xu Liu, Congxin Huang, Bo Yang, Bo Shen, Tao Liu, He Huang and Wei Gong. Their work appears in journals such as Blood, Molecular Biology Reports, Frontiers in Cardiovascular Medicine, The FASEB Journal and Journal of Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.